Sodium Channel Splicing in Heart Failure Trial (SOCS-HEFT) Prospective Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 450 participants.

Also called NCT02738749

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 450 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02738749
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02738749. Allocation not applicable; no masking; primary purpose other. Start 2014-06 (registry gives no type); primary completion 2019-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sodium Channel Splicing in Heart Failure Trial (SOCS-HEFT) Prospective Study
Condition
Death, Sudden, Cardiac
Intervention (Device)
Implantable cardioverter-defibrillator (ICD)
Lead sponsor
Rhode Island Hospital (class: other)

Record details

Record id
cardio:ct-nct02738749
Content hash
59d4f1485e8a043d923788e986709efbdeeb8f5fd0b1f41eec32752c9da5c14e